Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Kinhult

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS studyKatja Werlenius, Florida Parcaoglu, Mark Zupancic, et al.
F1000Research|January 17, 2019
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trialAsgeir Store Jakola, Katja Werlenius, Munila Mudaisi, et al.
JAMA Network Open|March 31, 2023
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical TrialKatja Werlenius, Sara Kinhult, Tora Skeidsvoll Solheim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2023
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Annals of Surgery|February 29, 2024
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUMRoger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Neuro-Oncology|April 10, 2017
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)Riccardo Soffietti, Ufuk Abacioglu, Brigitta Baumert, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countriesLiv Cathrine Heggebø, Taran Paulsen Hellebust, Thomas Henry, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS studyKatja Werlenius, Florida Parcaoglu, Mark Zupancic, et al.
F1000Research|January 17, 2019
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trialAsgeir Store Jakola, Katja Werlenius, Munila Mudaisi, et al.
JAMA Network Open|March 31, 2023
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical TrialKatja Werlenius, Sara Kinhult, Tora Skeidsvoll Solheim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2023
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Annals of Surgery|February 29, 2024
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUMRoger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Neuro-Oncology|April 10, 2017
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)Riccardo Soffietti, Ufuk Abacioglu, Brigitta Baumert, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countriesLiv Cathrine Heggebø, Taran Paulsen Hellebust, Thomas Henry, et al.
Pageof 3